Home › NDC Lookup › RxCUI directory › RxCUI 1866551

1 ML nalbuphine hydrochloride 20 MG/ML Injection — RxCUI 1866551

Name: 1 ML nalbuphine hydrochloride 20 MG/ML Injection (RxCUI 1866551)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1866551 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1866551

Official name1 ML nalbuphine hydrochloride 20 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asnalbuphine HCl 20 MG per 1 ML Injection; nalbuphine HCl 20 MG in 1 ML Injection

FDA products mapped6

Package NDCs mapped6

Reported Medicaid activity (SDUD)1,144 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nalbuphine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Nalbuphine is a prescription opioid pain reliever given by injection when your pain is severe enough that non-opioid medicines haven't been enough. It's also used by anesthesia tea...
What is nalbuphine injection actually used for?
Drowsiness is the most commonly reported side effect — it happens in a significant number of patients. You might also feel dizzy, sweaty, or a bit nauseous. Because of the sedation...
Will nalbuphine make me feel very drowsy or out of it?

📖 Read our full Nalbuphine Injection guide →

🕸️ Concept Web — How 1 ML nalbuphine hydrochloride 20 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1 ML nalbuphine hydrochloride 20 MG/ML Injection RxCUI 1866551 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Nalbuphine 7238 IN
- Nalbuphine hydrochloride 154985 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Nalbuphine Injection 1866542 SCDF
- Nalbuphine hydrochloride Injection 2648863 SCDFP
- Nalbuphine Injectable Product 1156970 SCDG
- Nalbuphine hydrochloride Injectable Product 2660692 SCDGP
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Nalbuphine hydrochloride 20 MG/ML 904439 SCDC

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Nalbuphine hydrochloride 20 MG/ML SCDC · 904439
Nalbuphine Injection SCDF · 1866542
Nalbuphine hydrochloride Injection SCDFP · 2648863
Nalbuphine Injectable Product SCDG · 1156970
Nalbuphine hydrochloride Injectable Product SCDGP · 2660692

📦 FDA Products & Package NDCs

6 products · 6 package NDCs

6 package NDCs map to RxCUI 1866551 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00409-1463-01	10 AMPULE in 1 TRAY (0409-1463-01) / 1 mL in 1 AMPULE (0409...	Nalbuphine Hydrochloride	Hospira, Inc.	2005-03-31
00409-1464-01	25 CARTON in 1 CASE (0409-1464-01) / 1 VIAL, MULTI-DOSE in...	Nalbuphine Hydrochloride	Hospira, Inc.	2005-07-19
00409-1465-01	10 AMPULE in 1 TRAY (0409-1465-01) / 1 mL in 1 AMPULE (0409...	Nalbuphine Hydrochloride	Hospira, Inc.	2004-12-31
00409-1467-01	25 CARTON in 1 CASE (0409-1467-01) / 1 VIAL, MULTI-DOSE in...	Nalbuphine Hydrochloride	Hospira, Inc.	2005-05-16
70069-0671-10	10 AMPULE in 1 CARTON (70069-671-10) / 1 mL in 1 AMPULE (70...	Nalbuphine hydrochloride	Somerset Therapeutics, LLC	2024-09-25
70069-0672-10	10 AMPULE in 1 CARTON (70069-672-10) / 1 mL in 1 AMPULE (70...	Nalbuphine hydrochloride	Somerset Therapeutics, LLC	2024-09-25

Observed labelers: Hospira, Inc. (4) · Somerset Therapeutics, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2300	Inj nalbuphine hydrochloride	6	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.